Home > Financial Ratios > JENBURKT PHARMACEUTICALS

JENBURKT PHARMACEUTICALS
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for JENBURKT PHARMACEUTICALS
Please provide your vote to see the results

JENBURKT PHARMACEUTICALS Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Margin(%) 25.9226.6323.3322.2121.98

What is the latest Core EBITDA Margin ratio of JENBURKT PHARMACEUTICALS ?

The latest Core EBITDA Margin ratio of JENBURKT PHARMACEUTICALS is 25.92 based on Mar2026 Standalone results.
Year Core EBITDA Margin
Mar202625.92
Mar202526.63
Mar202423.33
Mar202322.21
Mar202221.98

How is Core EBITDA Margin of JENBURKT PHARMACEUTICALS Trending?

Years Core EBITDA Margin % Change
Mar2026 25.92
-2.67
Mar2025 26.63
14.14
Mar2024 23.33
5.04
Mar2023 22.21
1.05
Mar2022 21.98 -

Other Financial Ratios of JENBURKT PHARMACEUTICALS


Compare Core EBITDA Margin ratio of peers of JENBURKT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JENBURKT PHARMACEUTICALS ₹467.2 Cr -0.1% -2.5% -17.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹461,848.0 Cr -1.4% -1.3% 21.5% Stock Analytics
DIVIS LABORATORIES ₹225,648.0 Cr 2.7% 16.1% 38.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹184,109.0 Cr -1.5% -3.3% 35.6% Stock Analytics
CIPLA ₹117,139.0 Cr -0.7% 1.4% -2% Stock Analytics
DR REDDYS LABORATORIES ₹100,328.0 Cr 3.9% -1.8% 0.4% Stock Analytics


JENBURKT PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
JENBURKT PHARMACEUTICALS

-0.1%

-2.5%

-17.3%

SENSEX

-0.6%

1.1%

-3.2%


You may also like the below Video Courses